Bio-Thera Reports Positive Bevacizumab Results

Avastin Rival Is Firm’s Second Biosimilar With Positive Phase III Outcome

 
• By Dave Wallace

China’s Bio-Thera Solutions has reported positive Phase III results for its proposed bevacizumab biosimilar rival to Avastin.

Clinical_Trial_Tablet
Bio-Thera Reports Positive Results For Its Bevacizumab Candidate • Source: Shutterstock

More from Biosimilars

More from Products